Medical Frontier: Breakthroughs from Chinese Hospitals – Page 3

Medical Frontiers

Breakthroughs, new diagnostics and complex procedures reported by Chinese hospitals.

All stories International patient stories (11) Oncology (35) Neurology & neurosurgery (26) Cardiology & heart surgery (14) Rare & hard-to-treat diseases (48) Orthopedics & sports medicine (3) Endocrine (1) Infectious disease (1) ENT & hearing (1) Organ failure & transplant (6) Rheumatology & immunology (1) Eye (2)

48 stories

Rare & hard-to-treat diseases2026-01-19

Shanghai Children's Medical Center Launches World's First Base Editing Clinical Study for Pediatric Chylomicronemia Syndrome

Professor Wang Xiumin's team at Shanghai Children's Medical Center led the launch of the world's first in vivo base editing drug clinical study for pediatric and adolescent familial chylomicronemia syndrome, exploring the safety and efficacy of LNP-delivered gene editing therapy. The hospital has built a registry of nearly 10,000 rare disease cases and conducts multiple cutting-edge studies including AADC deficiency gene therapy.

Shanghai Children's Medical Center

Rare & hard-to-treat diseasesInternational patient story2026-01-12

24,000㎡ Independent Dedicated Area! Shenzhen People's Hospital International Medical Department Officially Established

The hospital inaugurated its International Medical Department featuring a dedicated independent 24,000㎡ area. It provides multilingual services, direct international insurance billing, one-stop high-end medical services, and integrates academician team resources for overseas patients and high-end conferences.

Shenzhen People's Hospital

Rare & hard-to-treat diseases2025-12-29

Leads Release of Nation's First 'AI Doctor' Application Standard in Surgical Field

In collaboration with multiple organizations, the hospital developed thoracic surgery AI doctor standards, specifying requirements for medical expertise, interactive services, and safety ethics. This promotes standardized AI application in thoracic surgery decision-making and perioperative management.

Peking University People's Hospital

Guangzhou Medical University First Affiliated Hospital Xenogeneic Lung Transplant Research Selected as 2025 Nature Medicine Breakthrough

Video

Rare & hard-to-treat diseases2025-12-21

Guangzhou Medical University First Affiliated Hospital Xenogeneic Lung Transplant Research Selected as 2025 Nature Medicine Breakthrough

He Jianxing and Xu Xin's team conducted the world's first subclinical gene-edited porcine-to-human lung xenotransplantation, monitoring pulmonary function for 216 hours and addressing key immunological barriers. It is among the 12 major global biomedical breakthroughs of the year.

The First Affiliated Hospital of Guangzhou Medical University

Rare & hard-to-treat diseases2025-12-04

World's First Fully Automated Robot-Assisted Endovascular Aneurysm Repair Performed

Lu Qingsheng's team successfully completed a fully automated robot-assisted EVAR procedure, advancing vascular interventional surgery toward standardization and automation.

Changhai Hospital

Rare & hard-to-treat diseases2025-12-02

Innovative Drug Brings New Hope: Beijing Children's Hospital Helps 'Ultra-Rare Child Patient' Escape 'Infusion Bag' Dependence

The General Surgery Department applied teduglutide, the world's first innovative drug for short bowel syndrome, successfully helping the child restore autonomous intestinal function and completely eliminate the need for parenteral nutrition support. This accumulates valuable clinical experience in rare disease treatment.

Beijing Children's Hospital, Capital Medical University

Rare & hard-to-treat diseases2025-11-28

World's First Clinical-Grade Multimodal Oral Pathology Large Model Deployed at West China Stomatology

The HXDental-PathAI model developed by the hospital is now in clinical use in pathology, covering intelligent diagnosis of over 30 oral diseases with 98% sensitivity and 97% specificity for benign-malignant differentiation. It supports precision diagnostics and young physician training.

West China Hospital of Stomatology, Sichuan University

Rare & hard-to-treat diseases2025-11-18

Domestic 'Newton' Surgical Robot Achieves Fully Autonomous Collaborative Surgery

The domestic 'Newton' full-process endoscopic minimally invasive robot demonstrated its first fully autonomous collaborative surgery at an orthopedics academic conference and received high praise from experts. Equipped with AI intelligent planning, force-feedback dual robotic arms, and multimodal postoperative evaluation modules, it achieves sub-millimeter precision and revolutionizes orthopedic diagnosis and treatment paradigms.

Qilu Hospital of Shandong University

Rare & hard-to-treat diseases2025-11-14

CAR-NK Therapy for Systemic Lupus Erythematosus Published in The Lancet

Zhao Dongbao and Gao Jie's team performed the world's first allogeneic CAR-NK treatment for refractory SLE, with most patients achieving durable remission. A cell therapy center was established concurrently.

Changhai Hospital

World's First Remote Robotic Subretinal Injection Surgery Successfully Implemented

Video

Rare & hard-to-treat diseases2025-11-02

World's First Remote Robotic Subretinal Injection Surgery Successfully Implemented

Led by Lin Haotian's team, Zhongshan Ophthalmic Center used a domestic 5G ophthalmic surgical robot to complete the world's first micron-level remote subretinal injection spanning 4200 km from Guangzhou to Urumqi. This breakthrough advances remote high-precision ophthalmic surgery to practical application.

Zhongshan Ophthalmic Center, Sun Yat-sen University

Rare & hard-to-treat diseases2025-10-29

In Vivo CAR-T Therapy SNC116 Completes First Patient Enrollment

Shenogen Biotechnology's in vivo CAR-T product SNC116 targeting CD19 initiated clinical research at the Cancer Hospital of the Chinese Academy of Medical Sciences and completed enrollment of the first patient. It aims to solve accessibility issues associated with traditional CAR-T therapies.

Cancer Hospital, Chinese Academy of Medical Sciences

World's First Cross-Border Remote Robot-Assisted Cardiac Intervention Completed in Xiamen

Video

Rare & hard-to-treat diseasesInternational patient story2025-10-29

World's First Cross-Border Remote Robot-Assisted Cardiac Intervention Completed in Xiamen

Chinese and French experts collaborated via remote control platform to complete robot-assisted TEER, resulting in near-zero mitral regurgitation with the patient discharged. The procedure validated the feasibility and safety of remote precision control in real clinical settings.

The Affiliated Cardiovascular Hospital of Xiamen University